Prothena | PRTA - PE Price to Earnings


Prothena reported 22.11 in PE Price to Earnings for its fiscal quarter ending in March of 2022.





Pe Change Date
Acadia Pharmaceuticals 11.61 2.09 Dec/2025
Agios Pharmaceuticals 3.56 0.68 Sep/2025
Akebia Therapeutics 26.5 0.19 Sep/2023
ALKERMES 19.54 4.64 Dec/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amgen 25.31 15.82 Dec/2025
Biogen 14.02 4.63 Dec/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Exelixis 602.31 586.25 Dec/2025
Incyte 14.84 2.79 Dec/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Neurocrine Biosciences 835.47 802.2 Dec/2025
Prothena 22.11 11.37 Mar/2022
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Vertex Pharmaceuticals 26.15 2.22 Dec/2025
Xoma 52.12 3.09 Sep/2022